论文部分内容阅读
目的:评价三磷酸胞苷二钠的安全性和有效性,并与脑活素比较。方法:236例急性脑血管疾病患者随机分成两组,使用三磷酸胞苷二钠和脑活素进行治疗。结果:治疗组和对照组有效率分别为74.2％和50.9％,两者有显著性差异。不良反应率分别为13.3％和19.0％。结论:三磷酸胞苷二钠是治疗急性脑血管病安全有效的药物。
OBJECTIVE: To evaluate the safety and efficacy of cytidine triphosphate disodium, compared with cerebrolysin. Methods: A total of 236 patients with acute cerebrovascular disease were randomly divided into two groups and treated with cytidine triphosphate disodium and cerebrolysin. Results: The effective rates of the treatment group and the control group were 74.2% and 50.9%, respectively, with significant differences between the two groups. Adverse reaction rates were 13.3% and 19.0%, respectively. Conclusion: Disodium cytidine triphosphate is a safe and effective drug for the treatment of acute cerebrovascular disease.